• Molecular NameCefotiam
  • SynonymCefotiam hydrochloride; Cefotiamum [INN-Latin]; CTM
  • Weight525.639
  • Drugbank_IDDB00229
  • ACS_NO61622-34-2
  • Show 3D model
  • LogP (experiment)-1.005
  • LogP (predicted, AB/LogP v2.0)-0.7
  • pkaN/A
  • LogD (pH=7, predicted)-3.21
  • Solubility (experiment)Soluble
  • LogS (predicted, ACD/Labs)(ph=7)-3.28
  • LogSw (predicted, AB/LogsW2.0)44.68
  • Sw (mg/ml) (predicted, ACD/Labs)0.26
  • No.of HBond Donors4
  • No.of HBond Acceptors13
  • No.of Rotatable Bonds10
  • TPSA251.3
  • StatusFDA approved
  • AdministrationIntravenous, intramuscular
  • PharmacologyA second-generation cephalosporin antibiotic.
  • Absorption_valueN/A
  • Absorption (description)Rapidly absorbed following intramuscular injection. Bioavailability is 60% following intramuscular injection.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding40.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life1 h
  • ExcretionRenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityAdverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A